SEROLOGICALS CORPORATION 5,562,860 Shares of Common Stock Underwriting AgreementSerologicals Corp • December 17th, 2004 • Biological products, (no disgnostic substances) • New York
Serologicals Corporation, a Delaware corporation (the "Company"), proposes to issue and sell to the several Underwriters listed in Schedule I hereto (the "Underwriters"), for whom you are acting as representative (the "Representative"), an aggregate of 4,200,000 shares of Common Stock, par value $0.01 per share, of the Company and, at the option of the Underwriters, up to an additional 630,000 shares of Common Stock, solely to cover over-allotments. In addition, the stockholders named in Schedule II hereto (the "Selling Stockholders") propose to sell to the Underwriters an aggregate of 1,362,860 shares of Common Stock. The aggregate of 5,562,860 shares to be sold by the Company and the Selling Stockholders is herein called the "Underwritten Shares" and the aggregate of 630,000 additional shares that may be sold by the Company to cover over-allotments is herein called the "Option Shares". The Underwritten Shares and the Option Shares are herein referred to as the "Shares". The shares of
